Building partnerships through collaboration.
A University Institutional Biosafety Committee (IBC) has been created in accordance with requirements set forth in the National Institutes of Health "Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules". All research investigations involving recombinant nucleic acids, infectious agents, oncogenic materials or agents and toxins, must be registered with the IBC.
Meetings of the IBC will be open to the public, provided sufficient notice is given to the chairman so that adequate meeting space can be obtained. Only those parts of meetings dealing with privileged information (i.e., technical details of grant applications that have not been approved and funded) will remain closed. EH&S will maintain, for public viewing, minutes of committee meetings, information about future meetings, a lay summary of each recombinant DNA proposal submitted by principal investigators, and a list of reference material helpful to an understanding of the procedures involved in studies of recombinant DNA molecules.